Search results for "CAI"

showing 10 items of 579 documents

Evaluation of the plasmatic level of mepivacaine in different anatomical regions

2018

Background To evaluate the serum level of the local anesthetic mepivacaine 3% without vasoconstrictor in patients who underwent procedures performed in the anterior and posterior maxilla, through a method of possible extraction to quantify it in human plasma by high performance liquid chromatography (HPLC). Material and Methods This was a hybrid study consisting of 18 patients (7 females and 11 males) classified as ASA I, adults and with normal body mass index, submitted to procedures in the anterior region (group I) and posterior region of the maxilla (group II). For 40 minutes, five 6 ml blood samples were collected every 10 minutes after infiltrative injection in each region of the maxil…

AdultMalemedicine.drug_classGroup iiMepivacaineBlood PressureHigh-performance liquid chromatographyHeart RateHeart rateMaxillaHumansMedicineAnesthetics LocalGeneral DentistryAgedAged 80 and overbusiness.industryLocal anestheticResearchSignificant differenceMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Blood pressureOtorhinolaryngologyMaxillaAnesthesiaMepivacaineUNESCO::CIENCIAS MÉDICASFemaleSurgeryOral Surgerybusinessmedicine.drug
researchProduct

Addictive Severity in Cocaine Addicts Measured with the EuropASI: Differences between Composite Scores and Severity Ratings

2009

In this study we present the addiction severity profile in a sample of 202 cocaine addicts, using the composite scores for each area of the EuropASI (European version of the ASI), which are compared with the severity ratings obtained through interviewers' subjective assessments. The results showed that the areas of the EuropASI which reflected the greatest severity according to the composite scores were, in the following order: employment/support, family/social situation, use of alcohol and psychiatric state. The results obtained with the composite scores show discrepancies with those obtained from the severity rating. Statistically significant differences were found in the areas of alcohol…

AdultMalemedicine.medical_specialtyAddictionmedia_common.quotation_subjectReproducibility of ResultsMedicine (miscellaneous)Severity of Illness IndexSocial situationCocaine-Related DisordersPsychiatry and Mental healthClinical PsychologyInterview PsychologicalmedicineHumansFemalePsychiatryPsychologymedia_commonClinical psychologyAmerican Journal on Addictions
researchProduct

Comparison of 4% articaine with epinephrine (1:100,000) and without epinephrine in inferior alveolar block for tooth extraction: double-blind randomi…

2011

The purpose of this clinical prospective, randomized, double-blind study was to compare the anesthetic efficacy of 4% articaine with epinephrine (1:100,000) and without epinephrine in inferior alveolar nerve block anesthesia for extractions of mandibular teeth.Eighty-eight patients received intraoral inferior alveolar nerve blocks using 4% articaine with 1:100,000 epinephrine (n = 41; group 1) or without epinephrine (n = 47; group 2) for extractions of mandibular teeth. The primary objectives were differences in onset as well as in length of soft tissue anesthesia. The amount of anesthetic solution, need of a second injection, pain while injecting, pain during treatment, postoperative pain,…

AdultMalemedicine.medical_specialtyAdolescentEpinephrineAnesthesia DentalMandibular NerveOperative TimeMandibular nerveCarticaineAnesthetic AgentInferior alveolar nerveArticainePathology and Forensic Medicinelaw.inventionYoung AdultCarticaineDouble-Blind MethodRandomized controlled triallawHumansVasoconstrictor AgentsMedicineRadiology Nuclear Medicine and imagingDentistry (miscellaneous)Prospective StudiesAnesthetics LocalAgedAged 80 and overPain PostoperativeChi-Square Distributionbusiness.industryNerve BlockMiddle AgedSurgeryEpinephrineAnesthesiaTooth ExtractionAnestheticFemaleSurgeryOral Surgerybusinessmedicine.drugOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
researchProduct

Effect of intravenous flecainide on atrial vulnerability in man.

1985

Sixteen patients were investigated by means of programmed atrial stimulation at 2 different driving rates: 100/min and 120/min. All patients had an increased atrial vulnerability at both driving rates. After the administration of intravenous flecainide (1 mg/kg bodyweight as a bolus, followed by the same amount infused over a period of 20 minutes), the increased vulnerability was abolished in 11 and 9 patients, respectively. In the remaining patients the rate of induced atrial tachyarrhythmia decreased. These findings correlate with a significant prolongation of the effective refractory period of the right atrium and a corresponding significant shortening of its relative refractory period. …

AdultMalemedicine.medical_specialtyAdolescentRefractory Period ElectrophysiologicalRefractory periodElectrocardiographyBolus (medicine)PiperidinesInternal medicinemedicineHumansPharmacology (medical)Infusions ParenteralHeart AtriaFlecainideAgedFlecainidemedicine.diagnostic_testbusiness.industryAtrial vulnerabilityEffective refractory periodAtrial fibrillationArrhythmias CardiacMiddle Agedmedicine.diseaseAtrial FlutterAnesthesiaCardiologyFemalebusinessElectrocardiographyAnti-Arrhythmia AgentsAtrial fluttermedicine.drugDrugs
researchProduct

Effect of intravenous flecainide on atrial vulnerability in man.

1983

Sixteen patients were investigated by means of programmed atrial stimulation at two different driving rates: 100 and 120/min. All patients had an increased atrial vulnerability at both driving rates. After intravenous flecainide application (1 mg/kg body weight as a bolus followed by the same amount given by infusion over a period of 20 min) the increased vulnerability was abolished in 11 and 9 patients respectively. In the remaining patients the rate of induced atrial tachyarrhythmia decreased. These findings correlate with a significant prolongation of the effective refractory period of the right atrium and a significant shortening of the relative refractory period of the right atrium. It…

AdultMalemedicine.medical_specialtyAdolescentRefractory periodBody weightElectrocardiographyBolus (medicine)PiperidinesHeart Conduction SystemInternal medicineDrug DiscoveryAtrial FibrillationmedicineHumanscardiovascular diseasesFlecainideGenetics (clinical)AgedFlecainidebusiness.industryAtrial vulnerabilityEffective refractory periodCardiac Pacing ArtificialGeneral MedicineAtrial arrhythmiasMiddle Agedmedicine.anatomical_structureAtrial Fluttercardiovascular systemCardiologyMolecular MedicineRight atriumFemalebusinessAnti-Arrhythmia Agentsmedicine.drugKlinische Wochenschrift
researchProduct

Corneal thickness differences between sexes after oxybuprocaine eye drops.

2014

PURPOSE We aimed to analyze the corneal thickness (CT) values of female and male subjects before and after instillation of oxybuprocaine 0.4% anesthetic eye drops. METHODS The CT of 30 female subjects and 28 male subjects was measured using scanning-slit corneal topography (Orbscan Topography System II, Orbscan, Inc, Salt Lake City, UT). Measurements were carried out before and 3 minutes after the instillation of oxybuprocaine 0.4% eye drops. RESULTS The difference between the baseline values and those obtained after anesthesia ranged as follows: male subjects: central, -26 to +24 μm; superior, -24 to +23 μm; inferior, -19 to +20 μm; nasal, -25 to +30 μm; and temporal, -21 to +20 μm; female…

AdultMalemedicine.medical_specialtyAdolescentSalt lakeCorneaYoung AdultSex FactorsOphthalmologymedicineHumansProspective StudiesOxybuprocaineAnesthetics LocalBaseline valuesmedicine.diagnostic_testbusiness.industryCorneal TopographyOrgan SizeCorneal topographyOphthalmologyAnestheticFemaleOphthalmic SolutionsbusinessProcaineOptometrymedicine.drugOptometry and vision science : official publication of the American Academy of Optometry
researchProduct

Corneal Thickness Response after Anesthetic Eye Drops: Our Own Results and Meta-Analysis.

2017

We aimed to test if there are different patterns in the central corneal thickness (CCT) response after instilling oxybuprocaine anesthetic eye drops and also to determine whether there is a significant change in the CCT. CCT was measured in 60 eyes of 60 healthy subjects before and during the hour after oxybuprocaine 0.4% eye drops were instilled. In addition, a systematic review and meta-analysis were carried out in order to answer the following PICO (patient, intervention, comparison, and outcome) question: What effect do anesthetic eye drops have on CCT values? We found no significant changes in the mean CCT values during the hour’s observation (ANOVA, p=0.209), and the meta-analysis rev…

AdultMalemedicine.medical_specialtyArticle Subjectgenetic structureslcsh:MedicineGeneral Biochemistry Genetics and Molecular BiologyCornea03 medical and health sciences0302 clinical medicineOphthalmologyMedicineHumans030212 general & internal medicineProspective StudiesOxybuprocaineAnesthetics LocalGeneral Immunology and Microbiologybusiness.industrylcsh:RHealthy subjectsGeneral Medicineeye diseasesHealthy VolunteersMeta-analysisAnesthetic030221 ophthalmology & optometryFemaleAnalysis of variancesense organsOphthalmic SolutionsbusinessProcainemedicine.drugResearch ArticleBioMed research international
researchProduct

Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: A prospective study.

2020

Aim We aimed to identify whether lifetime cocaine use is a risk factor for conversion from major depressive disorder (MDD) to bipolar disorder (BD) in an outpatient sample of adults. Methods This prospective cohort study included 585 subjects aged 18 to 60 years who had been diagnosed with MDD as assessed by the Mini International Neuropsychiatric Interview (MINI-Plus) at baseline (2012-2015). Subjects were reassessed a mean of 3 years later (2017-2018) for potential conversion to BD as assessed by the MINI-Plus. Lifetime cocaine use was assessed using the Alcohol, Smoking, and Substance Involvement Screening Test. Results In the second wave, we had 117 (20%) losses, and 468 patients were r…

AdultMalemedicine.medical_specialtyBipolar DisorderAdolescentPoison control03 medical and health sciencesCocaine-Related DisordersYoung Adult0302 clinical medicineRisk FactorsInternal medicinemedicineHumansBipolar disorderProspective StudiesRisk factorProspective cohort studyMini-international neuropsychiatric interviewDepressive Disorder Majorbusiness.industryGeneral NeuroscienceGeneral MedicineMiddle Agedmedicine.diseaseConfidence interval030227 psychiatryPsychiatry and Mental healthNeurologyCohortDisease ProgressionMajor depressive disorderFemaleNeurology (clinical)business030217 neurology & neurosurgeryPsychiatry and clinical neurosciencesReferences
researchProduct

Haemodynamic effects of a single intravenous dose of lorcainide in patients with heart disease

1980

The cardiovascular effects of a single i.v. dose (2 mg/kg over 5 min) of lorcainide were studied in 14 patients with heart disease. In the haemodynamic part of the study (6 patients), the aortic and pulmonary systolic, diastolic and mean pressures, left ventricular systolic and end-diastolic pressures, cardiac output and the rate of rise of left ventricular pressure were measured before and for 30 min after administration of the drug. Lorcainide produced a slight and short-lasting decrease in the aortic and pulmonary systolic pressures, and all other pressure values remained unchanged. The cardiac output and systemic vascular resistance were not altered by lorcainide. It consistently depres…

AdultMalemedicine.medical_specialtyCardiac outputTime FactorsHeart DiseasesHeart diseaseBenzeneacetamidesDiastoleHemodynamicsBlood PressureLorcainidePiperidinesInternal medicinemedicineHumansPharmacology (medical)Cardiac OutputAgedPharmacologyEjection fractionbusiness.industryHeartGeneral MedicineMiddle Agedmedicine.diseaseMyocardial Contractionmedicine.anatomical_structureAnesthesiaVascular resistanceVentricular pressureCardiologyFemaleVascular ResistancebusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

High volume and low concentration of anaesthetic solution in the perivascular interscalene sheath determines quality of block and incidence of compli…

2006

Background and objective: In the perivascular sheath of the brachial plexus, the volume of anaesthetic solution determines the quality of anaesthetic cover. Fibrous septa may divide the perivascular space into compartments, leading to inadequate diffusion of the anaesthetic solution. The aim of our study was to obtain good anaesthesia and less complications using high volume of low concentration anaesthetic solution, overcoming the obstacle of the septa with a double approach to the scalene sheath. Methods: Sixty patients scheduled for shoulder capsuloplasty received both Winnie interscalene brachial plexus block and Pippa proximal cranial needle approach. The patients were randomly assigne…

AdultMalemedicine.medical_specialtyEpinephrineLidocaineBRACHIAL-PLEXUS BLOCK; BEZOLD-JARISCH REFLEX; SITTING POSITION; HEMIDIAPHRAGMATIC PARESIS; SHOULDER ARTHROSCOPY; FUNCTIONAL-ANATOMY; PULMONARY-FUNCTION; ULTRASONOGRAPHY; MEPIVACAINEFUNCTIONAL-ANATOMYMEPIVACAINEULTRASONOGRAPHYSITTING POSITIONAxillary blockBRACHIAL-PLEXUS BLOCKBradycardiaHumansMedicineBrachial PlexusAnesthetics LocalPerivascular spaceBEZOLD-JARISCH REFLEXVolume concentrationAgedBrachial plexus blockBupivacaineShoulder Jointbusiness.industryLidocainePULMONARY-FUNCTIONNerve BlockMiddle AgedAdrenergic AgonistsBupivacaineSurgeryParesisPhrenic NerveAnesthesiology and Pain Medicinemedicine.anatomical_structureAnesthesiaHEMIDIAPHRAGMATIC PARESISFemaleSHOULDER ARTHROSCOPYHypotensionbusinessBrachial plexusmedicine.drug
researchProduct